Dr. DeSimone received his B.S., M.S., and Ph.D. degrees from Temple University in Philadelphia. He has worked in both community and hospital practice. He also served as a consultant to the FDA, USP, and the pharmaceutical industry. He has been a Contributing Editor for U.S. Pharmacist since 1996. Dr. DeSimone has published more than 70 professional papers and has had chapters in three different textbooks. He taught at Butler University for 12 years and has been on the Creighton faculty since 1989. He serves as Professor of Pharmacy Sciences and currently teaches Calculations in Pharmacy Practice as well as a course on addiction and substance-related disorders.
Professor of Medicine in the Division of InfectiouUniversity of California, Los Angeles (UCLA), Health Sciences
Sexually Transmitted Disease, STI, HIV, AIDS, Public Health, Global Health, Infectious Disease
Dr. Jeffrey Klausner is an expert in infectious disease prevention and control. He is a frequent advisor to the Centers for Disease Control and Prevention and the World Health Organization (WHO). From 1998-2009, Klausner was a deputy health officer, director of STD prevention and control services at the San Francisco Department of Public Health and from 2009-2011 was branch chief for HIV and TB at the Centers for Disease Control, South Africa. Dr. Klausner research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB and cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. He has been a leading advocate in the use of medical male circumcision for HIV and STD prevention.
Cheryl Healton, DrPH, is dean of the College of Global Public Health and professor of public health policy and management at New York University. A public health leader and scholar, Healton has published more than 100 peer-reviewed papers and special reports on topics including HIV/AIDS, the opioid crisis, public health education, health policy, substance abuse, and tobacco. Healton was the founding president and CEO of Legacy (now Truth Initiative), a national foundation dedicated to tobacco control created by the tobacco industry’s Master Settlement Agreement. Healton worked to further the foundation’s mission: to build a world where young people reject tobacco and anyone can quit. During her time with Legacy, Healton guided the national youth tobacco prevention counter-marketing campaign, truth®, which has been credited with reducing youth smoking prevalence to near record lows. Healton is currently focused on what lessons can be learned from the tobacco industry’s Master Settlement Agreement and applied to other public health issues, including opioids, gun violence, obesity, and global warming. https://www.nejm.org/doi/10.1056/NEJMp1802633
Dan Polsky is a Bloomberg Distinguished Professor of Health Policy and Economics at Johns Hopkins University. Prior to joining Hopkins served as Executive Director of the Leonard Davis Institute of Health Economics from 2012 - 2019 and was a professor at the University of Pennsylvania in the Perelman School of Medicine and the Wharton School of Business. His research seeks an advanced understanding of the cost and quality tradeoff of health care intervention that addresses care, access, coverage, and payment.